ClinicalTrials.Veeva

Menu

Comparing Pain and Kinematic Outcomes of Two Gait-Modifying Shoe Interventions

University of Florida logo

University of Florida

Status

Withdrawn

Conditions

Arthritis Knee

Treatments

Device: Sole 2 - Neutral
Device: Sole 2 - Offset
Device: Sole 1 - Offset
Device: Sole 1 - Neutral

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03760380
OCR17682

Details and patient eligibility

About

This study involves the use of a newly designed shoe device for knee arthritis patients that may help reduce knee pain and improve function.

Full description

This study involves the use of a newly designed shoe device for knee arthritis patients that may help reduce knee pain and improve function. This is a 2-phase study designed to evaluate knee pain and function in healthy participants with a history of medial knee arthritis.

The purpose of this study is to evaluate: 1. how using the shoe device will affect a person's walking gait and balance over a single day; and 2. how using the shoe device over the course of a 12-week period will affect a person's walking gait and balance.

Sex

All

Ages

45 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic, OA-related knee pain
  • Diagnosis of medial compartment knee OA (unilateral or bilateral)
  • Moderate pain of ≥4 out of 10 points while performing a weight-bearing activity
  • Kellgren and Lawrence score of 2, 3, or 4 evidenced on routine, standard-of-care x-ray within the last 2 years prior to enrollment
  • Able to walk unassisted for at least 10 minutes at a time
  • Wear a Women's shoe size of 6.5 to 13 or a Men's shoe size of 5 to 12.

Exclusion criteria

  • Patients suffering from acute septic or inflammatory arthritis
  • Unstable cardiovascular, orthopaedic, or neurological conditions, uncontrolled diabetes, or any condition that would preclude exercise in moderate duration, moderate workload trials
  • Received a corticosteroid injection or invasive procedures within prior 6 months of the study
  • History of avascular necrosis in the knee
  • History of knee buckling
  • Joint replacement in any lower extremity joint that has not optimally recovered (e.g. still causes significant pain or affects mobility) as determined by the PI.
  • Experienced more than 3 falls within the last year
  • Currently using any knee brace on a regular basis for the knee pain, with the exception of basic knee sleeves
  • Pathological osteoporotic fracture
  • Severe symptomatic degenerative arthritis in lower limb joints other than the knees
  • Severe back pain, prior spinal fusion or spinal deformity that would affect gait
  • Major cardiac or pulmonary conditions and any orthopedic limitation that precludes their ability to independently walk for 10 minutes or longer
  • Knee flexion contracture greater than 15°
  • Knee flexion of less than 90°
  • Any major injury to either knee within the prior 12 months
  • Currently enrolled in a supervised physical therapy program

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Phase 1 Short Term
Experimental group
Description:
Participants will serve as their own control. Questionnaires and gait measures will be collected during an initial visit using the experimental shoe device. All subjects will perform the same procedures with all the experimental interventions (Sole 1 - Neutral, Sole 1--Offset, Sole 2 - Neutral, Sole 2 - Offset)
Treatment:
Device: Sole 2 - Offset
Device: Sole 1 - Offset
Device: Sole 1 - Neutral
Device: Sole 2 - Neutral
Phase 2 Long Term
Experimental group
Description:
Participants will serve as their own control. Questionnaires, balance, functional and gait measures will be collected during four different visits over a twelve week period (once at baseline visit, 4, 8, and 12 week visits) using the experimental shoe device. Patients will also complete a home walking program using the shoe device over the twelve week period. Subjects will be assigned one of two shoes/soles (either Sole 1-Offset or Sole 2- Offset) for home use.
Treatment:
Device: Sole 2 - Offset
Device: Sole 1 - Offset

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems